A randomized, parallel-arm, double blind, placebo-controlled study to assess the efficacy of fampridine for patients with spinocerebellar ataxia SCA27B caused by a GAA expansion in the FGF14 gene.(TREAT-FGF14)
RecruitingCTIS2024-520413-53-00
Assistance Publique Hopitaux De ParisSpinocerebellar ataxia
Start: 2025-10-21Target: 70Updated: 2025-08-01